Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein D1 (FOXD1) is a member of the forkhead box (FOX) family of transcription factors defined by a distinct DNA-binding forkhead domain. FOXD1 is essential for organogenesis, especially the development and morphogenesis of the kidney, retina, and optic chiasm. It plays critical roles in nephron progenitor differentiation, regional identity assignment in neural tissues, and regulation of cellular reprogramming. In cancer biology, FOXD1 is implicated as an oncogene, where increased expression correlates with higher tumor grade, poor prognosis, and chemoresistance. FOXD1 also helps regulate inflammatory reactions and prevent autoimmunity. Its broad developmental and cellular repertoire makes FOXD1 both a key biomarker and a putative therapeutic target in oncology and regenerative medicine, but also raises concerns for safe targeting given its essential role in normal tissue patterning and cell fate specification.
Regulation of PI3K/AKT/mTOR signaling pathway (promoting tumor progression/chemoresistance via FOXD1-AS1 in gastric cancer); Cell cycle progression modulation (targeting p27 in breast cancer).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein D1 (FOXD1).